- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 1315355-93-1] NG25
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-15434 |
| Brand: | MCE |
| CAS: | 1315355-93-1 |
Overview
| MDL | MFCD19443255 |
|---|---|
| Molecular Weight | 537.58 |
| Molecular Formula | C29H30F3N5O2 |
| SMILES | O=C(NC1=CC(C(F)(F)F)=C(CN(CC2)CCN2CC)C=C1)C3=CC(OC4=C5C(NC=C5)=NC=C4)=C(C)C=C3 |
22 Publications Citing Use of MCE
- [1]Nat Cell Biol. 2017 Oct;19(10):1248-1259.
- [2]Cell Death Differ. 2019 Dec;26(12):2520-2534.
- [3]J Cell Biol. 2018 Aug 6;217(8):2727-2742.
- [4]Oncogene. 2017 Oct 5;36(40):5620-5630.
- [5]Sci Signal. 2018 Jul 10;11(538). pii: eaan5850.
- [6]Cell Death Dis. 2022 Apr 30;13(4):421.
- [7]J Immunol. 2015 Aug 1;195(3):1100-11.
- [8]Biofactors. 2020 Sep;46(5):813-820.
- [9]J Am Heart Assoc. 2021 Feb 16;10(4):e014311.
- [10]J Cell Mol Med. 2020 Sep;24(18):10946-10957.
- [11]J Mol Cell Cardiol. 2021 Feb;151:31-43.
- [12]Sci Rep. 2016 Sep 7;6:32737.
- [13]Biochem Biophys Res Commun. 2014 Oct 10;453(1):106-11.
- [14]Mol Med Rep. 2018 Jan;17(1):1710-1716.
- [15]BMC Res Notes. 2022 Nov 26;15(1):352.
- [16]Oncotarget. 2021 Oct 12;12(21):2158-2168.
- [17]Institut für Zellbiologie und Immunologie der Universität Stuttgart. 2020 Sep.
- [18]Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine. 2020 Jul.
- [19]Oncotarget. 2017 Nov 1;8(61):104330-104346.
- [20]Oncotarget. 2016 Oct 25;7(43):69173-69187.
- [21]School of Medicine. University of North Carolina. 2016.
- [22]Harvard Medical School LINCS LIBRARY
Summary
NG25 is a potent dual TAK1 and MAP4K2 inhibitor, with IC 50 s of 149 nM and 21.7 nM, respectively.
IC50 & Target
|
MAP4K2 21.7 nM (IC 50 ) |
TAK1 149 nM (IC 50 ) |
LYN 12.9 nM (IC 50 ) |
GSK 56.4 nM (IC 50 ) |
ABL,ARG 75.2 nM (IC 50 ) |
FER 82.3 nM (IC 50 ) |
SRC 113 nM (IC 50 ) |
|
|
Eph B2 672 nM (IC 50 ) |
ZAK 698 nM (IC 50 ) |
Eph A2 773 nM (IC 50 ) |
Eph B4 999 nM (IC 50 ) |
ZC1/HGK 3250 nM (IC 50 ) |
RAF1 7590 nM (IC 50 ) |
||
In Vitro
NG25 is a potent dual TAK1 and MAP4K2 inhibitor, with IC 50 s of 149 nM and 21.7 nM, respectively. NG25 also potently suppresses several kinases such as LYN, CSK, FER, p38α, ABL,ARG and SRC, with IC 50 s of 12.9, 56.4, 82.3, 102, 75.2, and 113 nM, respectively [1] . NG25 is very potent suppressor of CpG B- or CpG A-stimulated secretion of IFNα and CL097-stimulated secretion of IFNβ, with complete inhibition by 400 nM [2] . NG25 treatment reduces cell viability of all tested breast cancer cell lines in a dose dependent manner. NG25 (2 μM) enhances the cytotoxic effect of Dox on breast cancer cells [3] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : 50 mg/mL ( 93.01 mM ; Need ultrasonic)
H 2 O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 1.8602 mL | 9.3009 mL | 18.6019 mL |
| 5 mM | 0.3720 mL | 1.8602 mL | 3.7204 mL |
| 10 mM | 0.1860 mL | 0.9301 mL | 1.8602 mL |
References
- [1] Tan L, et al. Discovery of type II inhibitors of TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2). J Med Chem. 2015 Jan 8;58(1):183-96.
- [2] Pauls E, et al. Essential role for IKKβ in production of type 1 interferons by plasmacytoid dendritic cells. J Biol Chem. 2012 Jun 1;287(23):19216-28.
- [3] Wang Z, et al. TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells. Sci Rep. 2016 Sep 7;6:32737.
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.